Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma

Upsala Journal of Medical Sciences

Volumn 118, Issue 2, 2013, Pages 91-97

  Mosavi, Firas ^a   Ullenhag, Gustav ^a   Ahlström, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DWI; Malignant melanoma; Whole body MRI

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84876098537     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2013.778375     Document Type: Article

References (18)

1. Vilanova JC, Barceló J. Diffusion-weighted whole-body MR screening. Eur J Radiol. 2008;67:440-7
2. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): Features and potential application in oncology. Eur Radiol. 2008;18:1937-52
3. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275-82
4. Mohr P, Eggermont AM, Hauschild A, Buzaid A. Staging of cutaneous melanoma. Ann Oncol. 2009;20:vi14-21
5. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34
6. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Régent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: Advantages of multi-contrast MRI examination including a diffusionweighted sequence in comparison with PET/CT. Eur J Radiol. 2010;75:376-83
7. Abdulqadhr G, Molin D, Åström G, Suurküla M, Johansson L, Hagberg H, et al. Whole-body diffusionweighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol. 2011;52:173-80
8. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47
9. Kartalis N, Loizou L, Edsborg N, Segersvärd R, Albiin N. Optimising diffusion-weightedMRimaging for demonstrating pancreatic cancer: A comparison of respiratory-Triggered, free breathing and breath-hold techniques. Eur Radiol. 2012;22: 2186-92
10. Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43:557-64
11. Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, et al. Screening for bone metastases: Whole-body MRI using a 32-channel system versus dual-modality PET/ CT. Eur Radiol. 2007;17:939-49
12. Lecouvet FE, Geukens D, Stainier A, Jamar F, d'Othée BJ, Therasse P, et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high risk prostate cancer: Diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol. 2007;25:3281-7
13. Takenaka D, Ohno Y, Matsumoto K, Aoyama N, Onishi Y, Koyama H, et al. Detection of bone metastases in non-small cell lung cancer patients: Comparison of whole-body diffusionweighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging. 2009;30:298-308
14. Müller-Horvat C, Radny P, Eigentler TK, Schäfer J, Pfannenberg C, Horger M, et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer. 2006;42:342-50
15. Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, et al. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol. 2011;66:224-36
16. Lambregts DM, Maas M, Cappendijk VC, Prompers LM, MottaghyFM, Beets GL, et al. Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer. 2011; 47:2107-16
17. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci. 2007;6:211-24
18. Padhani AR, Koh DM, Collins DJ. Whole-body diffusionweighted MR imaging in cancer: Current status and research directions. Radiology. 2011;261:700-18